Additionally, frequency of TCF7-expressing CD8+ T cells in melanoma can correlate to positive response to ICB, whereas in advanced clear cell renal carcinoma patients, it failed to predict any clinical outcomes (40, 41). This evidence concerns the gene TCF7 and melanoma.